Clorox (NYSE:CLX – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 6.650-6.900 for the period, compared to the consensus EPS estimate of 6.650. The company issued revenue guidance of $7.0 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion. Clorox also updated its FY25 guidance to $6.65-$6.90 EPS.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on CLX shares. Wells Fargo & Company dropped their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and lifted their price objective for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Barclays upped their target price on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research note on Friday. Evercore ISI lowered their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Six investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $150.29.
View Our Latest Analysis on Clorox
Clorox Price Performance
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 292.08% and a net margin of 4.78%. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 earnings per share. As a group, equities research analysts anticipate that Clorox will post 6.64 EPS for the current fiscal year.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.99%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 170.04%.
Insider Activity at Clorox
In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is owned by corporate insiders.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- How to Invest in Insurance Companies: A Guide
- Battle of the Retailers: Who Comes Out on Top?
- What does consumer price index measure?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- How to Use Stock Screeners to Find Stocks
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.